Emerging drugs for idiopathic pulmonary fibrosis

Author： Selman Moiséés   Pardo Annie   Richeldi Luca   Cerri Stefania  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.2, 2011-06, pp. : 341-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for idiopathic pulmonary fibrosis

By Thannickal Victor J   Flaherty Kevin R   Hyzy Robert C   Lynch 3rd Joseph P  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 707-727

Informa Healthcare

Access to resources Recommend Favorite

Current and emerging drugs for idiopathic pulmonary fibrosis

By Gharaee-Kermani Mehrnaz   Hu Biao   Thannickal Victor J   Phan Sem H   Gyetko Margaret R  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 627-646

Informa Healthcare

Access to resources Recommend Favorite

Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy

By Thannickal Victor J   Flaherty Kevin R   Martinez Fernando J   Lynch 3rd Joseph P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1671-1686

Informa Healthcare

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite